Supporting Programs for Lung Cancer Awareness and Screening
Lung Cancer Research Council programs are designed to create greater awareness about lung cancer and the importance of early detection through lung cancer screenings. Additionally, we are funding programs to encourage lung cancer screenings, targeting both physicians and their patients.
Our Lung Cancer Screening Initiatives
As a 100% volunteer organization, 100% of the funds we raise go to funding our mission. That includes supporting initiatives such as these.
- Funding digital Lung Cancer Screening Guidelines by the National Comprehensive Cancer Network (NCCN), the world’s foremost leader in producing screening guidelines
- Funding digital Lung Cancer Patient Guidelines by the NCCN
- Funding a low-dose CT screening trial in Charlotte County, Florida in conjunction with Millennium Physicians Group, Moffitt Cancer Center and Florida Cancer Specialists
- Funding a low-dose CT screening data collection project
- Lung cancer and lung cancer screening awareness
SW Florida Lung Cancer Screening Trial
In 2013 the United States Preventative Services Task Force (USPSTF) recommended Lung Cancer Screening using low-dose CT (LDCT) as the best method currently available to screen high risk, asymptomatic individuals for lung cancer. The USPSTF’s findings were based on the results of the National Lung Cancer Screening Trial (NLST), a 10-year $250 million study to determine the efficacy of using LDCT vs. X-Ray for lung cancer screening. The study was conducted using a cohort of 58,000 asymptomatic patients who were current or former smokers. The trial demonstrated that screening using LDCT reduced mortality from lung cancer by as much as 20 percent.
As a result of USPSTF’s recommendation, under the Affordable Care Act, people who are 55 to 79 years old with a history of smoking more than 30 cigarette packs a year are now eligible to be screened for lung cancer with no deductible or co-pay if they are current or former smokers who meet CMS guidelines. Former smokers are eligible if they quit within the last 15 years.
Despite the USPSTF’s recommendation, adoption and uptake of lung cancer screening has been low. The Lung Cancer Research Council and others believe the low accrual rates for lung cancer screening is attributed to lack of awareness of this modality among general practitioners and as well the general public.
The Lung Cancer Research Council approached Millennium Physician Group, Moffitt Cancer Center (MCC) and Florida Cancer Specialists (FCS) about jointly working on an observational lung cancer screening trial in SW Florida. The Lung Cancer Research Council has offered to fund a nurse navigator to serve as screening coordinator. Millennium, with a patient population of over 200,000, is uniquely positioned to recommend current and former smokers to be screened based on USPSTF’s recommended guidelines.
Early estimates show that the potential Millennium patient population may include a substantial number of current or former smokers, and many of these patients could be eligible for and benefit from annual screening. Patients who consent to share their de-identified data have the opportunity to contribute to the data collection targets of the screening trial.
The goal of the SW Florida Lung Cancer Screening Trial is to enroll and follow 1,000 patients over the course of three years to provide data about update, usage, and efficacy of screening. Moffitt Cancer Center will be leading efforts to collect, manage, and analyze data and Moffitt’s physicians will be available to assist with patient management, follow-up, and treatment decisions. FCS will be available locally to evaluate patients showing evidence of disease.
Millennium’s business model includes a focus on improved quality of patient care and experience as part of shared savings programs with various payors. As a result, the company’s goals are very much aligned with succeeding in the promotion of lung cancer screening as a preventative approach for their patients.
At the end of the three-year observational trial, our goal is to publish the results from this work in medical journals as a way of promoting lung cancer screening among physician groups across the country and create a template for broader adoption by physician groups.
How to Support These Programs
To support the above initiatives and the mission of Lung Cancer Research Council, get involved in our fundraising events, or make a donation today.